Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Bevacizumab

2 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCNEU17114

    04/18/2018

    A Randomized Phase 2 Trial of Cediranib and Olaparib Compared to Bevacizumab in Patients with Recurrent Glioblastoma who have not received Prior VEGF Therapy

    Treatment

    ECOGNEUA221208

    01/18/2017

    Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis after Radiosurgery for Brain Metastases


    Print this page for your doctor